TPG Capital
StanChart rules out KEB move
Standard Chartered has indicated that it will not be pursuing a bid for Korea Exchange Bank (KEB), further dampening expectations of a highly contested auction for Lone Star Funds' 51% stake in the asset.
Shan exits TPG for solo fund
Turnover at the top of TPG Capital in Hong Kong continues after the relocation of Dan Carroll, formerly Managing Partner with the firm in Hong Kong, to the West Coast.
Tenet backs out of Healthscope, citing disclosure
US hospitals group Tenet Healthcare Corp. has announced its withdrawal from bidding for Australian hospitals and pathology business Healthscope Ltd., leaving the two rival private equity consortia - Kohlberg Kravis Roberts & Co. and CVC Capital Partners...
Vishal Retail may turn to TPG, Indian investors for capital
Indian superstore chain owner Vishal Retail is considering linking with local and pan-regional investors, including private equity fund TPG Capital, within two to three months, to slash debt and raise capital following a fiscally-strained period.
Tenet could be out for Healthscope
US hospitals group Tenet Healthcare Corp. may withdraw from bidding for Australian hospitals and pathology business Healthscope Ltd., leaving competition for the A$1.84 billion ($1.56 billion) deal to the two rival private equity consortia of Kohlberg...
Shan quits TPG for own fund
Weijian Shan, hitherto Managing Partner with TPG Capital in Hong Kong and a leading regional investor for the firm, has now stepped down from his post in an apparently friendly departure, looking to form a new fund of his own.
CVC said joining KKR Healthscope bid
CVC Capital Partners may be joining Kohlberg Kravis Roberts & Co. in its A$1.84 billion ($1.56 billion) bid for Australia's Healthscope Ltd., in contention against a consortium of the Carlyle Group and TPG Capital, as well as Dallas-headquartered US strategic...
Khazanah, Fortis – and GIC? – square off for Parkway
Execution risks, possible challenge, in partial offer
Location, location, location
Hong Kong and Singapore residents have long been used to the competition between the two regional centers in terms of quality of life, friendliness to business, and just about every other metric going.
J-Will pips Advantage, TPG for Anabuki
Japanese private equity player J-Will Partners, acting in consortium with major local apartment developer Daikyo Inc., has entered the winning bid for bankrupt developer Anabuki Construction, winning out over some 30 bidders including Advantage Partners...
KKR, others cited for Healthscope
Kohlberg Kravis Roberts & Co. and an unnamed strategic bidder have been cited as the latest contenders for Australia's Healthscope Ltd., entering bids of around A$1.84 billion ($1.56 billion), marginally above the A$1.8 billion ($1.5 billion) already...
Khazanah seeks Parkway takeover
Malaysian SWF Khazanah Nasional is seeking to raise its stake in Parkway Holdings, the Singapore hospitals business recently exited by TPG Capital to India's Fortis Healthcare, from its present 23.5% to 51.5%, for some S$1.18 billion ($835 million).
Oz private equity tax ruling deferred indefinitely
The Australian Taxation Office (ATO) has deferred for the third time its long-awaited ruling on taxation of private equity profits in Australia, pending a government review of tax policy in the sector.
Healthscope: A healthy deal
Blackstone joins TPG and Carlyle in $1.5 billion bid
Advantage, J-Will, TPG in frame for Anabuki
Private equity bidders including Advantage Partners, J-Will Partners and TPG Capital are into the final round for Anabuki Construction Ltd., a defunct apartment developer based in Japan's southern island of Shikoku, in a deal worth at least $222 million...
CSRC review of MS CICC stake sale begins
Morgan Stanley has begun the formal application process to the China Securities Regulatory Commission (CSRC) for the sale of its 34.3% stake in PRC investment bank China International Capital Corp. (CICC).
Healthscope bidders raise price, nix breakup
The private equity bidders for ASX-listed hospital business Healthscope - still unconfirmed but widely reported as the Carlyle Group and TPG Capital - have raised their bid for the target to A$5.75 ($4.86) per share, totaling A$1.8 billion ($1.5 billion),...
Oz healthcare play, by who?
Australian private hospital and pathology operator Healthscope acknowledged receipt of an A$1.74 billion ($1.55 billion) takeover offer from an unnamed private equity consortium.
TPG sells Ping An H-shares
On the back of last week’s report that TPG Capital's legacy fund Newbridge Asia sold out its 16.76% stake in Shenzhen Development Bank to Ping An Insurance, the group has sold over half of the H-shares it received as payment into the market for a total...
TPG clear to exit China bank to Ping An
Strong turnaround not necessarily a precedent for sector
Keeping LPs happy
Fund administration services becoming more popular as investors become more demanding
GIC SI invests Fortis
GIC Special Investments, the private equity and alternatives arm of the Singapore SWF, is making an $84.5 million investment in India's Fortis Healthcare, for around 6.58% of the company's expanded capital.
TPG sees OK for SDB exit to Ping An
TPG Capital has had the way cleared for its exit from its pioneering PRC financial services investment Shenzhen Development Bank (SDB), as the China Securities Regulatory Commission (CSRC) gave Ping An Insurance Group approval to issue shares in exchange...
Dragon Capital sells Vietnam mining JV to TPG investee
Tiberon Minerals, owned by Vietnam-based investment firm Dragon Capital, will sell a control stake in the Nui Phao Mining Joint Venture Company, a tungsten mining project in development, to Masan Group, backed by TPG Capital.